Edgewise Therapeutics, Inc. (EWTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 509.79M | 543.38M | 573.9M | 603.25M | 443.18M | 475.48M | 499.44M | 519.44M | 541.43M | 327M | 297.92M | 317M | 333.36M | 357M | 370.14M | 253.34M | 268.62M | 283.77M | 293.24M | 302.97M |
| Cash & Short-Term Investments | 499.56M | 530.11M | 563.34M | 593.99M | 436.39M | 470.17M | 492.54M | 511.75M | 532.76M | 318.39M | 289.7M | 309.93M | 327.95M | 351.95M | 364.82M | 248.4M | 265.83M | 280.79M | 290.48M | 299.15M |
| Cash Only | 33.21M | 61.15M | 46M | 43.4M | 49.92M | 41.67M | 44.81M | 43.48M | 30.26M | 86.1M | 32.96M | 31.81M | 48.23M | 21.99M | 109.75M | 18.34M | 34.45M | 15.57M | 10.57M | 50.4M |
| Short-Term Investments | 466.35M | 468.96M | 517.34M | 550.59M | 386.47M | 428.5M | 447.73M | 468.27M | 502.5M | 232.3M | 256.74M | 278.12M | 279.72M | 329.95M | 255.07M | 230.05M | 231.38M | 265.22M | 279.91M | 248.75M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 10.23M | 13.28M | 10.56M | 9.26M | 6.79M | 5.31M | 6.9M | 7.69M | 8.67M | 8.6M | 8.22M | 7.07M | 5.41M | 0 | 0 | 0 | 0 | 2.98M | 2.76M | 3.82M |
| Total Non-Current Assets | 8.73M | 9.22M | 9.57M | 10.08M | 11.21M | 11.33M | 11.85M | 12.21M | 12.38M | 13.04M | 13.44M | 13.63M | 13.04M | 10.1M | 7.01M | 4.06M | 4.13M | 1.46M | 1.21M | 524K |
| Property, Plant & Equipment | 8.73M | 9.22M | 9.57M | 10.08M | 10.52M | 11.07M | 11.58M | 11.94M | 12.38M | 12.69M | 12.98M | 13.21M | 12.79M | 9.85M | 6.75M | 3.61M | 3.57M | 912K | 911K | 524K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 695K | 262K | 262K | 262K | 0 | 348K | 467K | 419K | 251K | 251K | 264K | 447K | 559K | 548K | 295K | 0 |
| Total Assets | 518.52M | 552.6M | 583.47M | 613.33M | 454.39M | 486.82M | 511.28M | 531.65M | 553.81M | 340.04M | 311.36M | 330.63M | 346.4M | 367.1M | 377.15M | 257.4M | 272.75M | 285.23M | 294.45M | 303.49M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 14.11% | 13.51% | 14.12% | 15.36% | -17.95% | 43.17% | 64.21% | 60.8% | 59.87% | -7.37% | -17.44% | 28.45% | 27.01% | 28.7% | 28.09% | -15.19% | -12.37% | 117.51% | - | - |
| Total Current Liabilities | 22.54M | 27.37M | 21.65M | 20.9M | 21.11M | 23.86M | 18.96M | 17.18M | 14.6M | 16.77M | 16.34M | 14.4M | 12.71M | 16.59M | 13.3M | 9.22M | 10M | 10.52M | 8.75M | 6.74M |
| Accounts Payable | 7.29M | 6.01M | 6.16M | 8.32M | 8.79M | 5.58M | 5.65M | 6.8M | 4.72M | 4.03M | 5.32M | 3.78M | 3.88M | 6.11M | 5.76M | 2.83M | 5.34M | 3.84M | 2.29M | 2.82M |
| Days Payables Outstanding | 1.01K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.02M | 1.01M | 1.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -988K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.23M | 20.35M | 14.48M | 5.94M | 3.97M | 10.06M | 6.18M | 988K | 2.92M | 5.7M | 4.41M | 3.13M | 2.07M | 4.03M | 2.7M | 2.02M | 0 | 0 | 0 | 0 |
| Current Ratio | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x | 26.35x | 30.24x | 37.08x | 19.50x | 18.23x | 22.01x | 26.22x | 21.53x | 27.82x | 27.49x | 26.85x | 26.97x | 33.50x | 44.96x |
| Quick Ratio | 22.61x | 19.85x | 26.51x | 28.87x | 20.99x | 19.93x | 26.35x | 30.24x | 37.08x | 19.50x | 18.23x | 22.01x | 26.22x | 21.53x | 27.82x | 27.49x | 26.85x | 26.97x | 33.50x | 44.96x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.78M | 2.98M | 3.17M | 3.37M | 3.56M | 3.74M | 3.45M | 4M | 4.26M | 4.43M | 4.6M | 4.77M | 4.84M | 3.8M | 2.45M | 1.83M | 2.38M | 329K | 295K | 0 |
| Long-Term Debt | 2.78M | 2.98M | 3.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59K | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 3.37M | 3.56M | 3.74M | 3.45M | 4M | 4.26M | 4.43M | 4.6M | 4.77M | 4.84M | 3.8M | 2.39M | 1.64M | 2.2M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192K | 187K | 329K | 295K | 0 |
| Total Liabilities | 25.32M | 30.35M | 24.82M | 24.26M | 24.67M | 27.6M | 22.41M | 21.17M | 18.86M | 21.2M | 20.94M | 19.17M | 17.56M | 20.39M | 15.75M | 11.04M | 12.39M | 10.85M | 9.05M | 6.74M |
| Total Debt | 3.79M | 3.99M | 4.18M | 4.37M | 4.56M | 4.74M | 4.44M | 4.99M | 5.25M | 5.41M | 5.53M | 5.64M | 5.64M | 4.41M | 2.66M | 1.74M | 2.2M | 0 | 0 | 0 |
| Net Debt | -29.42M | -57.16M | -41.82M | -39.03M | -45.36M | -36.93M | -40.37M | -38.5M | -25.02M | -80.68M | -27.43M | -26.16M | -42.59M | -17.59M | -107.08M | -16.6M | -32.26M | -15.57M | -10.57M | -50.4M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 493.2M | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M | 318.83M | 290.43M | 311.45M | 328.84M | 346.72M | 361.4M | 246.35M | 260.36M | 274.38M | 285.4M | 296.75M |
| Equity Growth % | 14.77% | 13.73% | 14.27% | 15.4% | -19.67% | 44.03% | 68.33% | 63.9% | 62.68% | -8.04% | -19.64% | 26.43% | 26.3% | 26.36% | 26.63% | -16.98% | -15.03% | 921.01% | - | - |
| Book Value per Share | 4.60 | 5.07 | 5.30 | 5.61 | 4.52 | 4.97 | 5.21 | 5.46 | 6.11 | 4.92 | 4.58 | 4.91 | 5.20 | 5.48 | 6.97 | 4.96 | 5.25 | 5.57 | 5.79 | 6.02 |
| Total Shareholders' Equity | 493.2M | 522.26M | 558.65M | 589.07M | 429.72M | 459.22M | 488.88M | 510.47M | 534.94M | 318.83M | 290.43M | 311.45M | 328.84M | 346.72M | 361.4M | 246.35M | 260.36M | 274.38M | 285.4M | 296.75M |
| Common Stock | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 7K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K |
| Retained Earnings | -595.38M | -546.37M | -496.15M | -455.49M | -419.37M | -378.58M | -338.91M | -304.79M | -273.29M | -244.76M | -214.62M | -188.91M | -167.44M | -144.6M | -125.19M | -107.69M | -91.62M | -76.96M | -64.26M | -51.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -252K | 677K | 701K | 204K | 401K | 420K | 1.05M | -1.05M | -861K | 99K | -424K | -547K | -251K | -1.35M | -2.18M | -2.34M | -1.93M | -514K | -24K | -33K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |